Stephen J. Hill

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Mark Meltz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen J. Hill:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Chief Operating Officer Common Stock 15,750 $253,890 $16.12 10 Nov 2025 Direct
Lyell Immunopharma, Inc. Chief Operating Officer Option (right to buy) 75,000 27 Oct 2025 Direct

Insider Reports Filed by Stephen J. Hill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LYEL Lyell Immunopharma, Inc. 10 Nov 2025 1 -$1,531 4 Chief Operating Officer 12 Nov 2025, 20:31
LYEL Lyell Immunopharma, Inc. 27 Oct 2025 1 $0 4 Chief Operating Officer 29 Oct 2025, 17:42
LYEL Lyell Immunopharma, Inc. 20 Aug 2025 2 -$10,586 4 Chief Operating Officer 22 Aug 2025, 16:06
LYEL Lyell Immunopharma, Inc. 11 Aug 2025 2 -$1,930 4 Chief Operating Officer 13 Aug 2025, 21:09
LYEL Lyell Immunopharma, Inc. 10 Feb 2025 3 $0 4 Chief Operating Officer 26 Feb 2025, 19:31
LYEL Lyell Immunopharma, Inc. 09 Feb 2024 2 $0 4 Chief Operating Officer 13 Feb 2024, 20:24
LYEL Lyell Immunopharma, Inc. 16 Nov 2023 12 $0 4 Chief Technical Ops. Officer 20 Nov 2023, 20:52
LYEL Lyell Immunopharma, Inc. 24 Feb 2023 1 $0 4 Chief Technical Ops. Officer 28 Feb 2023, 17:21
LYEL Lyell Immunopharma, Inc. 16 Mar 2022 1 $0 4 Chief Technical Ops. Officer 18 Mar 2022, 16:05
LYEL Lyell Immunopharma, Inc. 16 Jun 2021 0 $0 3 Chief Technical Ops. Officer 16 Jun 2021, 19:15